Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT02789501

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02789501
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
Austria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02789501. Randomized; single masking; primary purpose prevention. Start 2012-01 (registry gives no type); primary completion 2016-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
Condition
Catheter Infections
Condition
End-stage Renal Disease
Intervention (Device)
4% citrate lock solution regimen
Intervention (Device)
TauroLock lock solution regimen
Lead sponsor
Medical University of Vienna (class: other)

Record details

Record id
cardio:ct-nct02789501
Content hash
15aa16d1ed1da637ca4b47290cd18ed55b7552b679833e1375420cc96f35e139